Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (621-630 of 765) with videos related to

Pageof 77
Sort By:
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Internal Medicine|October 12, 2020
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisMario Gaudino, Irbaz Hameed, Michael E Farkouh, et al.
JACC. Basic to Translational Science|August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CADLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal|August 4, 2022
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 weekRaffaele De Caterina, Stefan Agewall, Felicita Andreotti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Circulation|October 18, 2021
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart DiseasePaolo Calabrò, Felice Gragnano, Giampaolo Niccoli, et al.
Pharmacogenomics|March 28, 2017
Institutional profile: University of Florida Health Personalized Medicine ProgramLarisa H Cavallari, Kristin W Weitzel, Amanda R Elsey, et al.
Journal of the American Heart Association|February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial InfarctionGiulia Magnani, Diego Ardissino, KyungAh Im, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
Pageof 77

Showing results (621-630 of 765) with videos related to

Sort By:
Pageof 77
Cardiovascular Diabetology|October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trialChao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Internal Medicine|October 12, 2020
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisMario Gaudino, Irbaz Hameed, Michael E Farkouh, et al.
JACC. Basic to Translational Science|August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CADLuis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
European Heart Journal|August 4, 2022
Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 weekRaffaele De Caterina, Stefan Agewall, Felicita Andreotti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2020
Correction: Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Circulation|October 18, 2021
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart DiseasePaolo Calabrò, Felice Gragnano, Giampaolo Niccoli, et al.
Pharmacogenomics|March 28, 2017
Institutional profile: University of Florida Health Personalized Medicine ProgramLarisa H Cavallari, Kristin W Weitzel, Amanda R Elsey, et al.
Journal of the American Heart Association|February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial InfarctionGiulia Magnani, Diego Ardissino, KyungAh Im, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 18, 2020
Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selectionAmber L Beitelshees, James M Stevenson, Nihal El Rouby, et al.
Thrombosis and Haemostasis|November 28, 2022
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesTobias Koch, Shqipdona Lahu, J J Coughlan, et al.
Pageof 77